Challenges related to development of bioabsorbable vascular stents

EuroIntervention

Volumn 5, Issue SUPPL. F, 2009, Pages

  Berglund, Joseph ^a   Guo, Ya ^a   Wilcox, Josiah N ^a  

^a MEDTRONIC INC   (United States)

Author keywords

Bioabsorbable; Stent

Indexed keywords

ANTITHROMBOCYTIC AGENT; CHROMIUM; COBALT; MAGNESIUM; NITINOL; POLY(ORTHO ESTER); POLYCAPROLACTONE; POLYDIOXANONE; POLYGLACTIN; POLYGLYCOLIDE; POLYLACTIDE; STAINLESS STEEL;

BARE METAL STENT; BIOCOMPATIBILITY; BIODEGRADABILITY; BIODEGRADABLE IMPLANT; CORONARY ARTERY DISEASE; CORONARY STENT; DEVICE SAFETY; DRUG ELUTING STENT; EQUIPMENT DESIGN; HUMAN; NONHUMAN; PERIPHERAL OCCLUSIVE ARTERY DISEASE; REVIEW; STENT; STENT THROMBOSIS; SUPERFICIAL FEMORAL ARTERY; VISCOELASTICITY;

EID: 79954463697     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/eijv5ifa12     Document Type: Review

References (21)

1. Gruentzig AR, Senning A, Siegenthaler WE. Non-operative dilatation of coronary artery stenoses. Percutaneous transluminal coronary angioplasty. N Engl J Med 1979;301:61-8. (Pubitemid 9229695)
2. Coronary Stent Market data from Medtronic, Inc.
3. King SB, (III), Smith (Jr), SC, Hirshfeld JW, Jacobs AK, Morrison DA, Williams DO, Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention A Report of the American College of Cardiology/American Heart Association task force on practice guidelines. Circulation 2008;117:261-95.
4. Mauri L, Hsieh WH, Massaro JM, Ho KKL, D'Agostino R, Cutlip DE. Stent thrombosis in randomized clinical trials of drug-eluting stents. New Engl J Med 2007;356:1020-9. (Pubitemid 46376802)
5. Millennium Research Group. Global Peripheral Vascular Device Market Webinar. Accessed from Medtronic, Inc. September 8, 2009.
6. Horton CE, Adamson JE, Mladick RA, Carraway JH. Vicryl synthetic absorbable sutures. Am Surg 1974;40:729-31.
7. Carpenter Technology Corporation. Carpenter MP35N* Ni-Co-Cr-Mo Alloy, 15% Cold Reduction. http://www.matweb.com/search/datasheet.aspx?MatGUID: 66d74913c0d0411f923df53cd60a7ffc&ckck: 1, Accessed 8 September, 2009.
8. Serruys PW, Ormiston JA, Onuma Y, Regar E, Gonzalo N, Garcia- Garcia HM, Nieman K, Bruining N, Dorange C, Miquel-Hébert K, Veldhof S, Webster M, Thuesen L, Dudek D. A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods. Lancet 2009;373:897-910.
9. Holland SJ, Jolly AM, Yasin M, Tighe BJ. Polymers for biodegradable medical devices. II. Hydroxybutyrate-hydroxyvalerate copolymers: hydrolytic degradation studies. Biomaterials 1987; 8:289-95.
10. Erbel R, Di Mario C, Bartunek J, Bonnier J, de Bruyne B, Eberli FR, Erne P, Haude M, Bernd Heublein B, Horrigan M, Ilsley C, Böse D, Koolen J, Lüscher TF, Weissman N, Waksman R for the PROGRESS-AMS (Clinical Performance and Angiographic Results of Coronary Stenting with Absorbable Metal Stents) Investigators. Temporary scaffolding of coronary arteries with bioabsorbable magnesium stents: a prospective, non-randomised multicentre trial. Lancet 2007;369:1869-75.
11. Gogolewski S, Jovanovic M, Perren SM, Dillon JG, Hughes MK. Tissue response and in vivo degradation of selected polyhydroxyacids: polylactides (PLA), poly(3-hydroxybutyrate) (PHB) and poly(3-hydroxybutyrate- co-3-hydroxy-valerate) (PHB/HV). J Biomed Mater Res 1993;27:1135-48. (Pubitemid 23241077)
12. Carter AJ, Aggarwal M, Kopia GA, Tio F, Tsao PS, Kolata R, Yeung AC, Llanos G, Dooley J, Falotico R. Long-term effects of polymer-based, slow-release, sirolimus-eluting stents in a porcine coronary model. Cardiovasc Res 2004; 63:617-624. (Pubitemid 39078675)
13. Udipi K, Chen M, Cheng P, Jiang K, Judd D, Caceres A, Melder RJ, Wilcox JN. Development of a novel biocompatible polymer system for extended drug release in a next-generation drug-eluting stent. J Biomed Mater Res A 2008; 85:1064-71. (Pubitemid 351717975)
14. Hezi-Yamit A, Sullivan C, Wong J, David L, Chen M, Cheng P, Shumaker D, Wilcox J and Udipi K. Novel high throughput polymer biocompatibility screening designed for sar (structure-activity relationship): application for evaluating polymer coatings for cardiovascular drug-eluting stents. Comb Chem High Throughput Screen 2009;12:664-76.
15. No Authors. Stainless steel - grade 316 - properties, fabrication and applications. http://www.azom.com/Details.asp?ArticleID: 863#-Mechanical- Properties. 13 September, 2001. Accessed 7 September, 2009.
16. No Authors. Properties of nitinol. http://www.memry.com/resources/faq- properties.php. Accessed 7 September, 2009.
17. Mark JE. Physical Properties of Polymers Handbook. 2nd ed. New York, NY: Springer; 2007: 941.
18. Heublein B, Rohde R, Kaese V, Niemeyer M, Hartung W, Haverich A. Biocorrosion of magnesium alloys: a new principle in cardiovascular implant technology? Heart 2003;89:651-6. (Pubitemid 36606211)
19. Middleton JC, Tipton AJ. Synthetic biodegradable polymers as medical devices. Medical Plastics and Biomaterials Magazine. http://www.devicelink.com/ mpb/archive/98/03/002.html; March 1998; Accessed 7 September, 2009.
20. Avedesian MM. ASM Specialty Handbook Magnesium and Magnesium Alloys. Baker H, ed. Materials Park, OH: ASM International; 1999.
21. Lyu S, Schley J, Loy B, Lind D, Hobot C, Sparer R, Untereker D. Kinetics and time-temperature equivalence of polymer degradation. Biomacromolecules 2007;8:2301-10. (Pubitemid 47104318)